Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori proteins encompass a diverse array of surface-exposed and intracellular molecules essential for the bacterium's survival, colonization, and pathogenesis within the human gastric environment (StatPearls, 2023). Key surface proteins include urease, which neutralizes stomach acid by producing ammonia, and various adhesins like BabA and SabA that facilitate attachment to the gastric epithelium (Nature Reviews Microbiology, 2006). Intracellular targets include essential enzymes for DNA replication (DNA gyrase), protein synthesis (ribosomes), and cell wall assembly (penicillin-binding proteins), which are the primary focus of current antibiotic therapies (Journal of Clinical Medicine, 2020). Virulence factors such as CagA and VacA are also critical proteins that modulate host cell signaling and contribute to the development of gastric cancer and peptic ulcers (World Journal of Gastroenterology, 2014). Therapeutic strategies typically involve a combination of antibiotics and proton pump inhibitors to eradicate the infection by targeting multiple bacterial processes simultaneously (American College of Gastroenterology, 2017). The emergence of multi-drug resistant H. pylori strains remains a significant challenge in clinical management (Lancet Infectious Diseases, 2018).
Inhibition of cell wall synthesis (beta-lactams), inhibition of protein synthesis (macrolides, tetracyclines), inhibition of DNA synthesis (nitroimidazoles, fluoroquinolones), and neutralization of gastric acid (StatPearls, 2023).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple Helicobacter pylori surface and intracellular proteins (H. pylori proteins).